Press Releases
SAN DIEGO and Copenhagen, Denmark -‐-‐ May 16, 2016 – Evofem and WomanCare Global will join leading experts on women’s global health and rights in Copenhagen, Denmark, May 16-‐19, 2016, for Women Deliver 2016. Saundra Pelletier, the organizations’ CEO, will join more than 5,000 global leaders, including Melinda Gates, Dr. Jim Yong Kim, the President of World Bank, as well as policymakers, donors, activists, and journalists from around the globe to share their expertise, and call for a better future for girls and women everywhere.
With more than 225 million girls and women globally who say they would like to plan their next pregnancy but don’t have access to services, supplies or information, access and education around women’s reproductive health is a top global issue that will be addressed at the conference.
“It is critical for women to be able to decide if, how and when they will have children,” said Saundra Pelletier, Evofem’s CEO and WomanCare Global’s Founding CEO. “Women being able to make the best choices for themselves and their families is predicated on access to information and resources. Investing in women and girls is absolutely critical to the success of humanity.”
WCG and Evofem will exhibit in booth C4-‐37-‐38 and here is a list of activities taking place during the week at Women Deliver.
For those unable to join us at Women Deliver, the conference is offering Women Deliver Live with exclusive events, debates and one-‐on-‐one interviews. You can also follow us on Twitter (@EvofemInc,@SaundraCEO, @WomanCareGlobal), Facebook (Evofem, WomanCare Global), Instagram (WomanCare Global) and LinkedIn (Evofem, WomanCare Global) for updates from the conference.
About WomanCare Global
WomanCare Global is a global non-‐profit healthcare company founded in 2009, whose mission is to provide reproductive health solutions for women and girls around the world. Leveraging medical, social and commercial expertise, WCG has built a sustainable value chain that enables the reliable delivery of high-‐quality products and point of care services, resulting in more informed providers and more family planning options for women and girls. WCG’s hybrid model redirects financial surplus achieved from sales in developed countries to under-‐served markets thereby eliminating economic and geographic barriers and increasing impact. More information can be found at www.womancareglobal.org.
About Evofem
Evofem Holdings, Inc. seeks to address a growing global contraceptive market, while delivering effective, woman-‐controlled products with global distribution. Evofem has two lead product candidates: Amphora®, a vaginal contraceptive gel, and the Nestorone® Ring, a one-‐year contraceptive vaginal ring, both of which have completed Phase III clinical studies. For more information on the Company, visit www.evofem.com.